Europe Synthetic Biology Market Size to Hit USD 5.32 Billion by 2026

Europe Synthetic Biology Market (By Product: Oligonucleotide/Oligo Pools and Synthetic DNA, Enzymes, Cloning Technologies Kits, Xeno-Nucleic Acids, Chassis Organism; By Technology: NGS Technology, PCR Technology, Genome Editing Technology, Bioprocessing Technology, Other Technologies; By Application: Healthcare, Clinical, Non-healthcare; By End Use: Biotechnology and Pharmaceutical Companies, Academic and Research Institutes, Others) Industry Size, Share, Growth, Trends 2025 to 2035

Report Code : 583 | Published : 08 May 2026 | Delivery : Immediate | Format : Excel | Author : Aditi Shivarkar, Aman Singh

Revenue,

USD 4.55 Bn

Forecast Year,

USD 21.87 Bn

CAGR, 2026 - 2035

17%

Report Coverage

Europe

Download Databook

The Europe synthetic biology market size was estimated at USD 4.55 billion in 2025 and is projected to be worth around USD 21.87 billion by 2035, expanding at a CAGR of 17% from 2026 to 2035. The market is primarily driven by growing R&D, substantial investments, advancements in genome engineering, and strong demand in pharmaceutical applications.

Europe Synthetic Biology Market Statical Scope

Reports Attributes	Statistics
Market Size in 2025	USD 4.55 Billion
Market Size in 2026	USD 5.32 Billion
Market Size by 2035	USD 21.87 Billion
CAGR 2026 to 2035	17%
Base Year	2025
Forecast Period	2026 to 2035

The Europe synthetic biology market is also driven by the demand for biologics , advancements in AI-driven biological research, and growing agricultural and industrial biotechnology . Growing usage of gene technologies such as CRISPR also helps to fuel the growth of the market.

Europe Synthetic Biology Market, By Product Outlook

Segments	Shares (%)
Oligonucleotide / Oligo Pools & Synthetic DNA	32%
Enzymes	18%
Cloning Technologies Kits	14%
Xeno-Nucleic Acids	8%
Chassis Organism	28%

Oligonucleotide / Oligo Pools & Synthetic DNA - The segment holds 32% of the market share and is driven by its essential role in gene synthesis, sequencing, and expanding synthetic biology research activities across Europe.
Enzymes - The segment accounts for 18% of the market share and is driven by its critical function in DNA manipulation, amplification, and biochemical processing.
Cloning Technologies Kits - The segment has a notable share of 14% in the market and is supported by rising research initiatives and higher demand for efficient genetic engineering tools.

Europe Synthetic Biology Market, By Technology Outlook

Segments	Shares (%)
NGS Technology	24%
PCR Technology	20%
Genome Editing Technology	26%
Bioprocessing Technology	18%
Other Technologies	12%

NGS Technology- The segment accounts 24% of the market share and is supported by increasing demand for high-throughput sequencing and genomics analysis.
PCR Technology- The segment has a significant share of 20% in the market and is driven by its higher usage in diagnostics and genetic research.
Genome Editing Technology- The segment has a notable share of 26% in the market and is driven by strong adoption of advanced gene editing tools such as CRISPR.

Europe Synthetic Biology Market, By Application Outlook

Segments	Shares (%)
Healthcare	48%
Non-Healthcare	52%

Healthcare - The segment has a significant share of 48% in the market and is driven by its expanding applications in industrial biotechnology, agriculture, and environmental solutions.
Non-Healthcare - The segment holds a notable share of 52% in the market and is majorly propelled by its expanding applications in industrial biotechnology, agriculture, and environmental solutions.

Europe Synthetic Biology Market, By End Use Outlook

Segments	Shares (%)
Biotechnology and Pharmaceutical Companies	52%
Academic and Research Institutes	33%
Others (including Dental Clinics, etc.)	15%

Biotechnology and Pharmaceutical Companies- The segment has a dominating share of 52% of the market and is driven by strong R&D investments and increasing adoption of synthetic biology in drug discovery and development.
Academic and Research Institutes- The segment accounts 33% of the market share and is supported by robust research funding and innovation.

Top Companies in the Europe Synthetic Biology Market

Bota Biosciences Inc.
Codexis, Inc.
Creative Biogene.
Creative Enzymes.
Enbiotix, Inc.
Illumina, Inc.
Merck Kgaa (Sigma-Aldrich Co. Llc)
New England Biolabs
Eurofins Scientific
Novozymes
Pareto Bio, Inc.
Scarab Genomics, Llc
Synthego
Synthetic Genomics Inc.
Thermo Fisher Scientific, Inc.

Segments Covered in the Report

By Product

Oligonucleotide/Oligo Pools and Synthetic DNA
Enzymes
Cloning Technologies Kits
Xeno-Nucleic Acids
Chassis Organism

By Technology

NGS Technology
PCR Technology
Genome Editing Technology
Bioprocessing Technology
Other Technologies

By Application

Healthcare
- Clinical
  - Bio/Pharmaceuticals
  - Diagnostics
- Non-Clinical
Non-healthcare
- Biotech Crops
- Specialty Chemicals
- Bio-fuels
- Others

By End Use

Biotechnology and Pharmaceutical companies
Academic and Research Institutes
Others

List of Tables & Figures

List of Tables

Table 1: Europe Synthetic Biology Market Size, by Product, 2025-2035 (USD Billion)
Table 2: Europe Synthetic Biology Market Size, by Technology, 2025-2035 (USD Billion)
Table 3: Europe Synthetic Biology Market Size, by Application, 2025-2035 (USD Billion)
Table 4: Europe Synthetic Biology Market Size, by End Use, 2025-2035 (USD Billion)
Table 5: Europe Synthetic Biology Market Size, by Region, 2025-2035 (USD Billion)
Table 6: Europe Synthetic Biology Market Size, by Oligonucleotide/Oligo Pools and Synthetic DNA, 2025-2035 (USD Billion)
Table 7: Europe Synthetic Biology Market Size, by Enzymes, 2025-2035 (USD Billion)
Table 8: Europe Synthetic Biology Market Size, by Cloning Technologies Kits, 2025-2035 (USD Billion)
Table 9: Europe Synthetic Biology Market Size, by Xeno-Nucleic Acids, 2025-2035 (USD Billion)
Table 10: Europe Synthetic Biology Market Size, by Chassis Organism, 2025-2035 (USD Billion)
Table 11: Europe Synthetic Biology Market Size, by NGS Technology, 2025-2035 (USD Billion)
Table 12: Europe Synthetic Biology Market Size, by PCR Technology, 2025-2035 (USD Billion)
Table 13: Europe Synthetic Biology Market Size, by Genome Editing Technology, 2025-2035 (USD Billion)
Table 14: Europe Synthetic Biology Market Size, by Bioprocessing Technology, 2025-2035 (USD Billion)
Table 15: Europe Synthetic Biology Market Size, by Other Technologies, 2025-2035 (USD Billion)
Table 16: Europe Synthetic Biology Market Size, by Healthcare Application, 2025-2035 (USD Billion)
Table 17: Europe Synthetic Biology Market Size, by Clinical Application, 2025-2035 (USD Billion)
Table 18: Europe Synthetic Biology Market Size, by Non-Healthcare Application, 2025-2035 (USD Billion)
Table 19: Europe Synthetic Biology Market Size, by Biotechnology and Pharmaceutical Companies, 2025-2035 (USD Billion)
Table 20: Europe Synthetic Biology Market Size, by Academic and Research Institutes, 2025-2035 (USD Billion)
Table 21: Europe Synthetic Biology Market Size, by Others End Use, 2025-2035 (USD Billion)
Table 22: Germany Synthetic Biology Market Size, 2025-2035 (USD Billion)
Table 23: France Synthetic Biology Market Size, 2025-2035 (USD Billion)
Table 24: UK Synthetic Biology Market Size, 2025-2035 (USD Billion)
Table 25: Italy Synthetic Biology Market Size, 2025-2035 (USD Billion)
Table 26: Rest of Europe Synthetic Biology Market Size, 2025-2035 (USD Billion)

List of Figures

Figure 1: Europe Synthetic Biology Market Share, by Product, 2025 (%)
Figure 2: Europe Synthetic Biology Market Share, by Technology, 2025 (%)
Figure 3: Europe Synthetic Biology Market Share, by Application, 2025 (%)
Figure 4: Europe Synthetic Biology Market Share, by End Use, 2025 (%)
Figure 5: Europe Synthetic Biology Market Share, by Region, 2025 (%)
Figure 6: Europe Synthetic Biology Market Forecast, 2025-2035 (USD Billion)
Figure 7: Oligonucleotide and Synthetic DNA Segment Forecast, 2025-2035 (USD Billion)
Figure 8: Enzymes Segment Forecast, 2025-2035 (USD Billion)
Figure 9: Cloning Technologies Kits Segment Forecast, 2025-2035 (USD Billion)
Figure 10: Xeno-Nucleic Acids Segment Forecast, 2025-2035 (USD Billion)
Figure 11: Chassis Organism Segment Forecast, 2025-2035 (USD Billion)
Figure 12: NGS Technology Segment Forecast, 2025-2035 (USD Billion)
Figure 13: PCR Technology Segment Forecast, 2025-2035 (USD Billion)
Figure 14: Genome Editing Technology Segment Forecast, 2025-2035 (USD Billion)
Figure 15: Bioprocessing Technology Segment Forecast, 2025-2035 (USD Billion)
Figure 16: Healthcare Application Market Forecast, 2025-2035 (USD Billion)
Figure 17: Clinical Application Market Forecast, 2025-2035 (USD Billion)
Figure 18: Non-Healthcare Application Market Forecast, 2025-2035 (USD Billion)
Figure 19: Biotechnology and Pharmaceutical Companies Segment Forecast, 2025-2035 (USD Billion)
Figure 20: Academic and Research Institutes Segment Forecast, 2025-2035 (USD Billion)
Figure 21: Europe Country-wise Market Comparison, 2025-2035 (USD Billion)

Research Methodology

Related Databooks

March 2026